Denali Therapeutics GAAP EPS of -$0.73 in-line
Source: SeekingAlpha
2026-02-26 17:06:24 ET
More on Denali Therapeutics
- Denali Therapeutics Inc. (DNLI) Presents at 22nd Annual WORLDSymposium - Slideshow
- Denali Therapeutics Inc. (DNLI) Shareholder/Analyst Call Transcript
- Denali Therapeutics Inc. (DNLI) Shareholder/Analyst Call - Slideshow
- Denali Therapeutics prices stock offering at $17.50 per share
- Denali Therapeutics announces $200M proposed offering of common stock and pre-funded warrants
Read the full article on Seeking Alpha
For further details see:
Denali Therapeutics GAAP EPS of -$0.73 in-line
Denali Therapeutics Inc.
NASDAQ: DNLI
DNLI Trading
0.89% G/L:
$21.65 Last:
580,006 Volume:
$21.31 Open:
DNLI Latest News
February 26, 2026 04:01:00 pm
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
February 19, 2026 08:30:00 am
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
DNLI Stock Data
$3,127,833,066
136,297,507
0.26%
87
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
